Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer

NCT00006015 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

26

Enrollment

NIH

Sponsor class

Stopped lack of sufficient accrual

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: fluorouracil
DRUG: leucovorin calcium
DRUG: oxaliplatin

Sponsor

National Cancer Institute (NCI)